EXHIBIT 99.1
CREDIT SUISSE FIRST BOSTON (USA), INC. AND SUBSIDIARIES
(In millions)
|
| December 31, |
| December 31, |
| ||
ASSETS |
|
|
|
|
| ||
|
|
|
|
|
| ||
Cash and cash equivalents |
| $ | 334 |
| $ | 480 |
|
Collateralized short-term financings: |
|
|
|
|
| ||
Securities purchased under agreements to resell |
| 50,388 |
| 51,756 |
| ||
Securities borrowed |
| 77,999 |
| 71,296 |
| ||
Receivables: |
|
|
|
|
| ||
Customers |
| 2,859 |
| 1,079 |
| ||
Brokers, dealers and other |
| 6,673 |
| 7,060 |
| ||
Financial instruments owned (includes securities pledged as collateral of $47,565 and $49,695, respectively): |
|
|
|
|
| ||
U.S. government and agencies |
| 31,781 |
| 32,131 |
| ||
Corporate debt |
| 12,761 |
| 12,174 |
| ||
Mortgage whole loans |
| 9,101 |
| 9,465 |
| ||
Equities |
| 15,161 |
| 9,735 |
| ||
Commercial paper |
| 641 |
| 619 |
| ||
Private equity and other long-term investments |
| 1,123 |
| 956 |
| ||
Derivatives contracts |
| 5,573 |
| 3,956 |
| ||
Other |
| 3,765 |
| 3,085 |
| ||
Net deferred tax asset |
| 1,283 |
| 1,611 |
| ||
Office facilities and property at cost (net of accumulated depreciation and amortization of $865 and $749, respectively) |
| 468 |
| 485 |
| ||
Goodwill |
| 532 |
| 496 |
| ||
Loans receivable from parent and affiliates |
| 19,481 |
| 16,430 |
| ||
Other assets and deferred amounts |
| 1,643 |
| 2,094 |
| ||
Assets held for sale |
| — |
| 11,547 |
| ||
Total assets |
| $ | 241,566 |
| $ | 236,455 |
|
CREDIT SUISSE FIRST BOSTON (USA), INC. AND SUBSIDIARIES
(In millions, except share data)
|
| December 31, |
| December 31, |
| ||
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
|
| ||
|
|
|
|
|
| ||
Commercial paper and short-term borrowings |
| $ | 15,984 |
| $ | 11,933 |
|
Collateralized short-term financings: |
|
|
|
|
| ||
Securities sold under agreements to repurchase |
| 110,667 |
| 107,896 |
| ||
Securities loaned |
| 27,708 |
| 24,178 |
| ||
Payables: |
|
|
|
|
| ||
Customers |
| 4,278 |
| 2,928 |
| ||
Brokers, dealers and other |
| 5,410 |
| 8,689 |
| ||
Financial instruments sold not yet purchased: |
|
|
|
|
| ||
U.S. government and agencies |
| 23,700 |
| 22,710 |
| ||
Corporate debt |
| 2,523 |
| 3,315 |
| ||
Equities |
| 5,231 |
| 3,240 |
| ||
Derivatives contracts |
| 3,955 |
| 2,849 |
| ||
Other |
| 336 |
| 335 |
| ||
Obligation to return securities received as collateral |
| 1,955 |
| 896 |
| ||
Accounts payable and accrued expenses |
| 2,836 |
| 3,200 |
| ||
Other liabilities |
| 3,021 |
| 2,156 |
| ||
Long-term borrowings |
| 24,321 |
| 23,094 |
| ||
Liabilities held for sale |
| — |
| 10,947 |
| ||
Total liabilities |
| 231,925 |
| 228,366 |
| ||
|
|
|
|
|
| ||
Stockholders’ Equity: |
|
|
|
|
| ||
Preferred stock, 50,000,000 shares authorized: |
|
|
|
|
| ||
Series B preferred stock, at $50.00 per share liquidation preference (88,500 shares issued and outstanding as of December 31, 2002) |
| — |
| 4 |
| ||
Common stock ($0.10 par value; 50,000 shares authorized; 1,100 shares issued and outstanding) |
| — |
| — |
| ||
Paid-in capital |
| 8,012 |
| 7,646 |
| ||
Retained earnings |
| 1,787 |
| 595 |
| ||
Accumulated other comprehensive loss |
| (158 | ) | (156 | ) | ||
Total stockholders’ equity |
| 9,641 |
| 8,089 |
| ||
Total liabilities and stockholders’ equity |
| $ | 241,566 |
| $ | 236,455 |
|
